Dynamic BH3 profiling identifies active BH3 mimetic combinations in non-small cell lung cancer

por Potter, Danielle S., Du, Ruochen, Bhola, Patrick, Bueno, Raphael, Letai, Anthony
Publicado 2021

Retrospective Analysis of Real-World Management of EGFR-Mutated Advanced NSCLC, After First-Line EGFR-TKI Treatment: US Treatment Patterns, Attrition, and Survival Data

por Nieva, Jorge, Reckamp, Karen L., Potter, Danielle, Taylor, Aliki, Sun, Ping
Publicado 2022

The impact of initial antibiotic treatment failure: real-world insights in patients with complicated, health care-associated intra-abdominal infection

por Peeters, Pascale, Ryan, Kellie, Karve, Sudeep, Potter, Danielle, Baelen, Elisa, Rojas-Farreras, Sonia, Rodríguez-Baño, Jesús
Publicado 2019

Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma

por Potter, Danielle S., Du, Ruochen, Bohl, Stephan R., Chow, Kin-Hoe, Ligon, Keith L., Bueno, Raphael, Letai, Anthony
Publicado 2023

A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer

por Schabath, Matthew B, Dalvi, Tapashi B, Dai, Hongyue A, Crim, Alan L, Midha, Anita, Shire, Norah, Gimbrone, Nicholas T, Walker, Jill, Greenawalt, Danielle M, Lawrence, David, Rigas, James R, Brody, Robert, Potter, Danielle, Kumar, Naveen S, Huntsman, Shane A, Gray, Jhanelle E
Publicado 2019

Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active

por Garcia, Jacqueline S., Kim, Haesook T., Murdock, H. Moses, Cutler, Corey S., Brock, Jennifer, Gooptu, Mahasweta, Ho, Vincent T., Koreth, John, Nikiforow, Sarah, Romee, Rizwan, Shapiro, Roman, Loschi, Fiona, Ryan, Jeremy, Fell, Geoffrey, Karp, Hannah Q., Lucas, Fabienne, Kim, Annette S., Potter, Danielle, Mashaka, Thelma, Stone, Richard M., DeAngelo, Daniel J., Letai, Anthony, Lindsley, R. Coleman, Soiffer, Robert J., Antin, Joseph H.
Publicado 2021